
Curant Rare Partners as Exclusive Pharmacy for FDA-Approved Neuroblastoma Drug IWILFIN™
Curant Rare Becomes Exclusive Pharmacy Partner for IWILFIN™, Transforming Access and Care for High-Risk Neuroblastoma Patients Curant Health has announced a major milestone in oncology care through its specialty division,…













